Omnicell (OMCL) Net Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -641.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 420.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 484.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 459.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 941.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -1,024.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 574.00 |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 573.00 |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 663.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 663.00 |
| Mar 31, 2026 | 882.00 |
| Dec 31, 2025 | 890.00 |
| Sep 30, 2025 | -306.00 |
| Jun 30, 2025 | -80.00 |
| Mar 31, 2025 | -518.00 |
| Dec 31, 2024 | 67.00 |
| Sep 30, 2024 | -684.00 |
| Jun 30, 2024 | -614.00 |
| Mar 31, 2024 | -1,196.00 |
| Dec 31, 2023 | -1,213.00 |
| Sep 30, 2023 | -226.00 |
| Jun 30, 2023 | 331.00 |
| Mar 31, 2023 | -1,008.00 |
| Dec 31, 2022 | -1,844.00 |
| Sep 30, 2022 | -391.00 |
| Jun 30, 2022 | -461.00 |
| Mar 31, 2022 | 95.00 |
| Dec 31, 2021 | -249.00 |
| Sep 30, 2021 | 322.00 |